Multicenter Study for Robotic Arm-assisted THA 4.0 System: Hip Spine Relationship

August 17, 2021 updated by: Benjamin Domb, MD, American Hip Institute

Multicenter Study for Robotic Arm-assisted THA 4.0 System With Integration of Pelvic Tilt and ROM Assessments: Implant Position Accuracy and the Hip Spine Relationship

The current study is a multi-center study to assess precision and accuracy of the robotic system with new software.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Robotic-arm assisted surgery aims to reduce errors and improve accuracy for implant position in total hip arthroplasty (THA). In THA implant positioning plays a pivotal role in good clinical outcomes and reduces long-term wear, therefore, technology has been developed to help surgeons achieve more accurate implant position consistently. Computer-assisted navigation provides surgeon with knowledge to help guide surgeons intra-operatively with some systems computed tomography (CT)-based, others fluoroscopy based, and others imageless systems. Computer navigation has been shown to accurately place components, but does not provide the ability for patient specific pre-operative planning that CT- based robotics allows. While some may argue that robotic-arm assisted THA is more accurate, others argue that the cost and learning curve associated with robotic-arm assisted THA is not more accurate with no long-term clinical benefits. Robotic arm-assisted THA has been shown to improve accuracy of component placement and reduce outliers. Kayani et al reviewed 100 cases performed by a single surgeon with 50 THAs performed manually and 50 robotic arm-assisted. In this study, Kayani did not find a learning curve associated with achieving accuracy using the robotic arm-assisted technology; however, there was a 12 case learning curve for both himself and his operating staff that increased operative time [9]. Nodzo et al evaluated the use of the robotic arm-assisted THA using post-operative CT scans and found that both the acetabular and femoral component position were significantly accurate when compared to the intra-op position. Kamara et al reviewed a single surgeon case series to assess acetabular accuracy and found that 76% of manual THAs were within the surgeons' target zone compared to 97% of his robotic arm-assisted THAs, concluding that adoption of robotic arm-assisted THA provided significant improvement in acetabular component positioning during THA. Similarly, Redmond et al found that although there was a learning curve associated with robotic arm-assisted THA, operative time decreased with experience and acetabular component outliers decreased suggesting that while there is a learning curve with robotic arm-assisted THA the clinical benefits are better implant positioning and decreased outliers. Illgen et al reported that the improved acetabular accuracy in robotic arm-assisted THA significantly reduced dislocation rates when compared to manual THA. Bukowski et al reported robotic arm-assisted THA clinical outcomes at a minimum of 1 year and found that patients who underwent a robotic arm-assisted THA has higher clinical outcomes compared to a manual group, however, there have been no large multicenter studies that assess clinical outcomes after robotic arm-assisted THA.

In conjunction with numerous other patient-specific and surgical factors, such as age, sex, comorbidities, surgical approach, component selection, and impingement, component positioning is often cited as an important factor in optimizing THA stability. Lewinnek et al. defined the "safe zone" for component position as 40⸰±10⸰ of cup inclination and 15⸰±10⸰ of cup anteversion to minimize dislocation risk. However, recent studies have shown that not only do components continue to dislocate when placed in this zone, but that the majority of THA dislocations are positioned in this safe zone to begin with. Compounding this issue is the growing body of evidence showing that the acetabular component is not static in nature, as was the assumption with Lewinnek's safe zone, but rather dynamically changing with movement of the pelvis and spine during postural and positional changes. Alterations of the dynamic relationship between the hip, spine, and pelvis in patients with hip-spine pathology during movements such as transitioning from standing to sitting affects typical pelvic biomechanical accommodation, resulting in THA component impingement, instability, and dislocation. Therefore, patients with spinopelvic pathology secondary to arthritis, spinal fusion, or spinal deformity are more prone to dislocation and revision following primary THA. The standard modality for assessing hip component position postoperatively is a 2D anteroposterior radiograph, due to low radiation dose and low cost. However, hip replacement components are placed in a 3-dimensional pelvis and femur, and therefore an anteroposterior radiograph alone may not give accurate information on the anteversion of the acetabular or femoral component. Studies have shown that cup anteversion measured with radiographs can have serious deviations with a substantial error range (mean deviation +1.74°, range -16.6° to 29.8°). This is attributed to the fact that radiographs cannot control for pelvic rotation and/or tilt. Recently a limited number of studies have started to use the other imaging modalities for understanding pelvic tilt in patients undergoing hip arthroplasty.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Des Plaines, Illinois, United States, 60018
        • American Hip Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Requires primary total hip arthroplasty surgery
  • Willing and able to comply with postoperative follow up requirements
  • at least 18 years of age
  • sign an IRB approved informed consent

Exclusion Criteria:

  • body mass index >40
  • Skeletally immature
  • patient with active infection or suspected latent infection in or about joint
  • bone stock inadequate for support or fixation of the prosthesis
  • Neuromuscular disorders, muscle atrophy, or vascular deficient in the affected limb
  • Ankylosing spondylitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mako THA 4.0 group
Hip system used: femoral stem (Accolade II), acetabular cup (Trident II or MDM if necessary), femoral head (ceramic or metal head compatible with Accolade II), acetabular insert (X3 Trident II or MDM liner when using MDM cup). Mako THA 4.0 software also will be used.

Measure how the accuracy and precision of robotic arm-assisted total hip arthroplasty (THA) for placement accuracy of implant position in both the anterior and posterior approach.. The intervention will assess the precision of the MAKO system in placing hip components according to plan. It will compare hip angles executed by the Mako system intraoperatively with the 'gold standard' of 3D computer tomography (CT) scans.

The postoperative CT scan can show the precision of the MAKO system by accurately determining the location of hip replacements in patients after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Computed Tomography scan. Placement accuracy of acetabular cup and femoral stem
Time Frame: 6 weeks postoperatively
Using computed tomography to assess placement accuracy, Measured in degrees
6 weeks postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic tilt
Time Frame: Preoperatively and postoperatively at 6 weeks and 1 year
measured preoperatively and intraoperatively in sitting and standing positions
Preoperatively and postoperatively at 6 weeks and 1 year
Virtual range-of-motion
Time Frame: Preoperatively and postoperatively at 6 weeks and 1 year
measured preoperatively and intraoperatively in sitting and standing positions using virtual range of motion impingement modeling
Preoperatively and postoperatively at 6 weeks and 1 year
Patient satisfaction
Time Frame: 1 year postoperative
Measured in a scale of 0-10 to determine how satisfied a patient is with their procedure. A score of 10 indicates most satisfied, a score of 0 is least satisfied.
1 year postoperative
Harris Hip Score
Time Frame: preoperative and 1 year postoperative
Questionnaire. A measure of functionality of the operated hip. Measured scale: 0-100. Lower score means worse functional outcome.
preoperative and 1 year postoperative
Forgotten Joint Score
Time Frame: 1 year postoperative
Assess likelihood the patient has forgotten that they had a hip replacement. Measured scale: 0-100. Higher score means better feeling of normalcy.
1 year postoperative
Hip Disability and Osteoarthritis Outcome Score
Time Frame: 1 year postoperative
Assess pain and function. Measured scale: 0-100. Higher the score, the greater the outcome and patient experience.
1 year postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benjamin G Domb, MD, American Hip Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Anticipated)

January 1, 2024

Study Completion (Anticipated)

January 1, 2024

Study Registration Dates

First Submitted

November 18, 2020

First Submitted That Met QC Criteria

November 20, 2020

First Posted (Actual)

November 27, 2020

Study Record Updates

Last Update Posted (Actual)

August 20, 2021

Last Update Submitted That Met QC Criteria

August 17, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Hip

Clinical Trials on MAKO THA 4.0 System

3
Subscribe